Hey Friends,
Help me make this year of Nina’s Notes great by filling out this quick survey. Share your feedback about Nina’s Notes and share some information about you so I can create the content you want to read.
It will take just 3 minutes to complete.
Thank you! Thank you!
On this episode I sit down with Keith C Ellis, PhD, an Associate Professor in the Department of Medicinal Chemistry at Virginia Commonwealth University and a natural products chemist.
He is the founder and CEO of Science-Driven Supplements, where he uses his knowledge of physiology, pharmacology, drugs, and natural products to create products to tackle big public health challenges.
Keith was frustrated with the treatment options for long COVID, and used his expertise in natural product chemistry to reverse engineer a solution based on the positive results shown from using anticoagulant drugs to treat long COVID.
The resulting product is called CircuGuard, which combines three natural ingredients that target the same biological pathways as triple anticoagulant therapy, in a dose which is safe for over-the-counter use.
Listen to the episode on 🟢 Spotify, 🟣 Apple Podcasts, 🟠 Substack Podcasts to learn the origin story of CircuGuard and how Keith came up with this solution to help the millions suffering from long COVID.
Key Takeaways:
There are over 400 million cases of long COVID projected worldwide.
Long COVID symptoms are diverse and not well-defined, therefore patients often experience frustration due to lack of clear diagnostics.
A new hypothesis suggests that microclots in the blood cause long COVID symptoms.
Unfortunately, testing for microclots is currently limited and not widely available.
Triple anticoagulant therapy shows promise but has safety concerns, and CircuGuard aims to provide a safer treatment option using natural anticoagulants for the treatment of long COVID.
Real-life testimonials highlight the positive impact of Circugard on long COVID symptoms.
Users are advised to take Circugard for three to six months for best results.
Listen now on Apple Podcasts, Spotify, and Substack Podcasts.
Recommended Timestamps
00:00 Introduction to Long COVID Research
06:00 The Microclots Hypothesis
11:58 Testing and Treatment for Microclots
22:24 Reverse Engineering Pharmaceutical Therapy
28:37 CircuGuard: Market Launch and Mission
34:50 Long COVID Treatment: Expectations and Recommendations
43:49 Advice for Entrepreneurs in Long COVID Research
Where to find Keith C. Ellis, PhD:
Where to find Nina Patrick, PhD:
Edited by Wright Time Publishing
